- Home
- TRMD vs CPRX Comparison
TRMD vs CPRX Comparison
Compare TRMD & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRMD
- CPRX
- Stock Information
- Founded
- TRMD 1889
- CPRX 2002
- Country
- TRMD United Kingdom
- CPRX United States
- Employees
- TRMD N/A
- CPRX N/A
- Industry
- TRMD Marine Transportation
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- TRMD Consumer Discretionary
- CPRX Health Care
- Exchange
- TRMD Nasdaq
- CPRX Nasdaq
- Market Cap
- TRMD 1.9B
- CPRX 2.5B
- IPO Year
- TRMD N/A
- CPRX 2006
- Fundamental
- Price
- TRMD $19.30
- CPRX $21.60
- Analyst Decision
- TRMD Buy
- CPRX Strong Buy
- Analyst Count
- TRMD 1
- CPRX 7
- Target Price
- TRMD $48.00
- CPRX $31.14
- AVG Volume (30 Days)
- TRMD 1.2M
- CPRX 872.1K
- Earning Date
- TRMD 11-07-2024
- CPRX 11-06-2024
- Dividend Yield
- TRMD 24.41%
- CPRX N/A
- EPS Growth
- TRMD N/A
- CPRX 114.68
- EPS
- TRMD 7.70
- CPRX 1.18
- Revenue
- TRMD $1,641,593,000.00
- CPRX $460,482,000.00
- Revenue This Year
- TRMD N/A
- CPRX $23.98
- Revenue Next Year
- TRMD N/A
- CPRX $18.27
- P/E Ratio
- TRMD $2.53
- CPRX $18.34
- Revenue Growth
- TRMD 3.90
- CPRX 32.17
- 52 Week Low
- TRMD $17.77
- CPRX $13.12
- 52 Week High
- TRMD $40.47
- CPRX $24.27
- Technical
- Relative Strength Index (RSI)
- TRMD 40.05
- CPRX 48.10
- Support Level
- TRMD $17.77
- CPRX $21.01
- Resistance Level
- TRMD $19.76
- CPRX $21.64
- Average True Range (ATR)
- TRMD 0.53
- CPRX 0.58
- MACD
- TRMD 0.29
- CPRX -0.04
- Stochastic Oscillator
- TRMD 64.44
- CPRX 32.76
About TRMD TORM plc
TORM PLC operates as a shipping company. The company owns and operates product tankers. It is engaged in the transportation of refined oil products The company transports clean petroleum products including gasoline, jet fuel, naphtha, and diesel oil, as well as other clean products. Its segments include the Tanker segment, and Marine Exhaust segment.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.